免疫治疗中的表型和向药物发现:挑战,机遇和未来方向
Nelson García Vázquez1, Hossam Nada1, Saurabh Upadhyay1
1Department of Radiology, Molecular Imaging Innovations Institute (MI3), Weill Cornell Medicine New York NY 10065 USA mog4005@med.cornell.edu.
RSC advances
|August 27, 2025
概括
这项研究探讨了免疫治疗的发展,强调了如何结合表型和基于目标的药物发现加速了创新. 采用人工智能和多态的综合方法是创造更有效的癌症和自身免疫疾病治疗方法的关键.
科学领域:
- 免疫学和药理学
- 药物发现和开发
背景情况:
- 免疫疗法改变了医学, 尤其是癌症和自身免疫性疾病.
- 传统的药物发现依赖于表型查和基于目标的方法.
- 表型查产生了新的疗法,而基于目标的方法允许精确的理性设计.
研究的目的:
- 审查表型和基于目标的药物发现战略的演变和整合.
- 突出关键的免疫调节药物及其发现途径.
- 检查新兴的混合方法以加速治疗发展.
主要方法:
- 对主要免疫调节药物 (免疫检查点抑制剂,双特异性抗体,小分子调节剂) 的审查.
- 发现途径和作用机制的分析.
- 综合计算,人工智能和多态技术的研究.
主要成果:
- 现型查已经确定了第一类疗法.
- 有针对性的方法使得基于分子机制的精确药物设计成为可能.
- 在计算建模,人工智能和多态学方面的进步加快了这两种策略的整合.
结论:
- 综合表型和基于目标的方法正在重塑药物发现管道.
- 连接功能和机械见解的混合方法对于加速发展至关重要.
- 未来的免疫药物发现需要适应性,整合性工作流程来提高有效性和克服耐药性.
更多相关视频
相关概念视频
Microorganisms in Medicine and Therapeutics
314
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
314
Drug Discovery: Overview
8.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.7K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
Cytotoxic T Cells-mediated Immune Response
1.9K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.9K
Targets for Drug Action: Overview
7.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.4K


